1. Ad hoc Working party on Biotechnology/Pharmacy. Note for guidance: CPMP Guideline: Validation of virus removal and inactivation procedures (III/8115/89). 1991, Feb, 11, 13
2. Commission of the European Communities, Ad hoc Working party on Biotechnology/Pharmacy. Contribution to Part II of the structure of the dossier for applications for marketing authorization – Control of starting materials for the production of blood derivatives. 1 July 1995
3. Note for guidance on plasma-derived medicinal products,1998
4. Viral contamination of human plasma and procedures for preventing virus transmission by plasma products;Cuthbertson,1991
5. Safety aspects in the manufacturing of plasma-derived coagulation factor concentrates;Burnouf;Biologicals,1992